Neurodegenerative and liver disease are among the targets of Regenerative Medicine Minnesota.
A spokesperson said that Medtronic didn’t yet know the total number of employees that would be impacted by their new restructuring plan, but that the company is still on track to make good on their pledge to create 1,000 jobs in the state since moving their HQ to Ireland in 2015.
Overall, the company expects to save the $3 billion by the end of its 2022 fiscal year.
A preclinical study between Mayo and collaborator Corindus Vascular Robotics will test a remote-controlled ‘telestenting’ system in face of likely cardiologist shortfall.
Todd Berg, who led local medical device company Torax Medical to a sale last year, is taking over as CEO of Metavention.
Zyga’s flagship product is used to treat chronic pain within the lower spine.
The medical device company expects to get FDA approval for its flagship product this year.
University professor Jerrold Vitek and the MnDRIVE program were key in approval for Parkinson’s treatment.
An Aussie firm with a Twin Cities headquarters is using circadian waves to identify depression types.